BEHIND THE NUMBERS - AstraZeneca aims for sales of $80 billion by 2030

  • 16 days ago
The Anglo-Swedish pharmaceutical company is aiming for sales growth of 75% over 7 years. How does it intend to achieve this?

Recommended